EarningsQ2 2024 Earnings Report

Mirum Pharmaceuticals (08D) Q2 2024 Earnings Report

0 Followers

DE:08D Q2 2024 EPS Results

Actual EPS-€0.46

Consensus EPS-€0.42

Beat/MissMissed by -€0.04

One Year Ago EPS-€1.73

Actual Revenue€69.36M

Expected Revenue€66.83M

Beat/MissBeat by +€2.53M

YoY Revenue Growth+107.68%

QuarterQ2 2024

Date08/07/2024

TimeAfter Close

Conference CallWednesday, August 7, 2024

DE:08D Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

DE:08D Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-0.44 / -	0.045	―
Aug 05, 2026	2026 (Q2)	-0.66 / -0.94	-0.107	-783.33% (-0.84)
May 06, 2026	2026 (Q1)	-0.33 / -11.96	-0.267	-4376.67% (-11.69)
Feb 25, 2026	2025 (Q4)	0.05 / -0.09	-0.436	79.59% (+0.35)
Nov 04, 2025	2025 (Q3)	-0.12 / 0.04	-0.267	116.67% (+0.31)
Aug 06, 2025	2025 (Q2)	-0.29 / -0.11	-0.463	76.92% (+0.36)
May 07, 2025	2025 (Q1)	-0.29 / -0.27	-0.481	44.44% (+0.21)
Feb 26, 2025	2024 (Q4)	-0.23 / -0.44	-0.561	22.22% (+0.12)
Nov 12, 2024	2024 (Q3)	-0.40 / -0.27	-0.508	47.37% (+0.24)
Aug 07, 2024	2024 (Q2)	-0.42 / -0.46	-1.728	73.20% (+1.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed